Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study

Rheumatoid Arthritis

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study

Semin Arthritis Rheum.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S

doi: 10.1016/j.semarthrit.

Psoriasis

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Br J Dermatol.

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group

doi: 10.1111/bjd.17036.

Autoimmune Disease

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults

Int J Cancer.

McGee EE, Castro FA, Engels EA, Freedman ND, Pfeiffer RM, Nogueira L, Stolzenberg-Solomon R, McGlynn KA, Hemminki K, Koshiol J

doi: 10.1002/ijc.31835.

Rheumatoid Arthritis

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Ann Rheum Dis.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC

doi: 10.1136/annrheumdis-

Further Publications Rheumatology

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Rheumatology (Oxford)

Krabbe S, Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Jarbøl DE, Østergaard M, Hetland ML

doi: 10.1093/rheumatology/keaa876

Rheumatoid Arthritis

Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease

Clin Rheumatol.

Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL

doi: 10.1007/

Rheumatoid Arthritis

Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data

BMJ Open.

Huang CM, Chen HJ, Huang PH, Tsay GJ, Lan JL, Sung FC

doi: 10.1136/bmjopen2017-

Further Publications Immunology

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA.

Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R

doi: 10.1001/jama.2017.16071.

Further Publications Rheumatology

Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections

Semin Arthritis Rheum

Beaufrère M, Pressat-Laffouilhère T, Marcelli C, Michon J, Lequerré T, Prum-Delépine C, Fiaux E, Rasoldier V, Etienne M, Savouré A, Dormoy L, Dargère S, Verdon R, Vittecoq O, Avenel G

doi: 10.1016/j.semarthrit.2021.08.008

Related content

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease

Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections